1. Why it matters: In India, stroke is a disease of all ages, and a leading cause of death and disability
  2. Innovation: heartMAP is a scalable anticoagulation program harnessing low-cost mobile technology to reduce death and disability from stroke in low-literacy, low-resource settings
  3. Measurable Impact: We project that heartMAP will reduce death and disability from stroke by 37% in our target population, and reduce monthly cost of anticoagulation by 60%
  4. How we started: We started as a class project at Stanford University’s design school (d.school)
  5. Meet Our Team: We are a diverse, interdisciplinary, international team of scientists and techies passionate about combating cardiovascular disease among the most vulnerable populations in the world